Matthew Winter

Consultant Medical Oncologist, Honorary Professor of Medical Oncology, School of Medicine and Population Health, University of Sheffield

Sheffield Teaching Hospitals NHS Foundation Trust

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matthew Winter is a Consultant Medical Oncologist and Honorary Professor of Medical Oncology at the School of Medicine and Population Health, University of Sheffield, UK. His research primarily focuses on gestational trophoblastic diseases, with recent publications covering treatment guidelines, monitoring practices, and patient experiences. He is affiliated with Sheffield Teaching Hospitals NHS Foundation Trust, where he contributes to advancing clinical practices in oncology.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (2)

Ehsan Ghorani

Associate Professor in Cancer Immunology

Imperial College London

UNITED KINGDOM

View details

Pierre-Adrien Bolze

Université Claude Bernard Lyon 1

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthew Winter

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study.

PITMEX Study: Prophylactic IntraThecal Methotrexate For Patients With Stage III Gestational Trophoblastic Neoplasia, A Retrospective Multicentric Comparative Study

Vaginal metastasis in gestational trophoblastic neoplasia: Experience from Sheffield trophoblastic disease Centre and recommendations for management

Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization

How long is hCG monitoring required after normalization following evacuation of a complete hydatidiform mole? A national, retrospective population study

Molar pregnancy: a qualitative study of personal experiences and societal narratives of loss

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial

Comparison of circulating tumor DNA assays for molecular residual disease detection in early-stage triple-negative breast cancer

Patients' experience of menopausal symptoms post-chemotherapy treatment for gestational trophoblastic neoplasia

Collaborators (2)

Ehsan Ghorani

Pierre-Adrien Bolze

Make your next move.